DE69731964D1 - Map-kinase: polypeptide, polynukleotide und ihre verwendung - Google Patents

Map-kinase: polypeptide, polynukleotide und ihre verwendung

Info

Publication number
DE69731964D1
DE69731964D1 DE69731964T DE69731964T DE69731964D1 DE 69731964 D1 DE69731964 D1 DE 69731964D1 DE 69731964 T DE69731964 T DE 69731964T DE 69731964 T DE69731964 T DE 69731964T DE 69731964 D1 DE69731964 D1 DE 69731964D1
Authority
DE
Germany
Prior art keywords
stress
protein kinase
activated protein
compound
polynucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69731964T
Other languages
English (en)
Other versions
DE69731964T2 (de
Inventor
Philip Cohen
Michel Goedert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Research Council
Original Assignee
Medical Research Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9621096.8A external-priority patent/GB9621096D0/en
Priority claimed from GBGB9709781.0A external-priority patent/GB9709781D0/en
Application filed by Medical Research Council filed Critical Medical Research Council
Publication of DE69731964D1 publication Critical patent/DE69731964D1/de
Application granted granted Critical
Publication of DE69731964T2 publication Critical patent/DE69731964T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69731964T 1996-10-09 1997-10-09 Map-kinase: polypeptide, polynukleotide und ihre verwendung Expired - Lifetime DE69731964T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9621096.8A GB9621096D0 (en) 1996-10-09 1996-10-09 Method
GB9621096 1996-10-09
GBGB9709781.0A GB9709781D0 (en) 1997-05-15 1997-05-15 Polypeptides,polynucleotides and uses thereof
GB9709781 1997-05-15
PCT/GB1997/002779 WO1998015618A1 (en) 1996-10-09 1997-10-09 Map kinases: polypeptides, polynucleotides and uses thereof

Publications (2)

Publication Number Publication Date
DE69731964D1 true DE69731964D1 (de) 2005-01-20
DE69731964T2 DE69731964T2 (de) 2005-12-08

Family

ID=26310195

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69731964T Expired - Lifetime DE69731964T2 (de) 1996-10-09 1997-10-09 Map-kinase: polypeptide, polynukleotide und ihre verwendung

Country Status (8)

Country Link
US (1) US6617117B1 (de)
EP (1) EP0932666B1 (de)
JP (1) JP2001501481A (de)
AT (1) ATE284955T1 (de)
AU (1) AU727733B2 (de)
CA (1) CA2267656A1 (de)
DE (1) DE69731964T2 (de)
WO (1) WO1998015618A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA73492C2 (en) 1999-01-19 2005-08-15 Aromatic heterocyclic compounds as antiinflammatory agents
GB9902696D0 (en) * 1999-02-09 1999-03-31 Medical Res Council Screening methods
JP2002537397A (ja) 1999-02-22 2002-11-05 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 抗炎症剤としての多環ヘテロ環式誘導体
EE04799B1 (et) 1999-03-12 2007-04-16 Boehringer Ingelheim Pharmaceuticals, Inc. Ühendid, mis on kasulikud põletikuvastaste vahenditena, nende ühendite valmistamise meetodid ja neid sisaldavad farmatseutilised kompositsioonid
WO2000055152A1 (en) 1999-03-12 2000-09-21 Boehringer Ingelheim Pharmaceuticals, Inc. Aromatic heterocyclic compounds as anti-inflammatory agents
WO2001004115A2 (en) 1999-07-09 2001-01-18 Boehringer Ingelheim Pharmaceuticals, Inc. Novel process for synthesis of heteroaryl-substituted urea compounds
US6525046B1 (en) 2000-01-18 2003-02-25 Boehringer Ingelheim Pharmaceuticals, Inc. Aromatic heterocyclic compounds as antiinflammatory agents
US6608052B2 (en) 2000-02-16 2003-08-19 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as anti-inflammatory agents
EP1174129A1 (de) * 2000-07-17 2002-01-23 Zenner, Hans Peter, Prof. Dr. med. Verwendung eines Matrix-Metalloproteinase-Inhibitors zur Behandlung von Krebs
WO2003072569A1 (en) 2002-02-25 2003-09-04 Boehringer Ingelheim Pharmaceuticals, Inc. 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459036A (en) * 1993-03-19 1995-10-17 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Extracellular signal-regulated kinase, sequences, and methods of production and use
US5736381A (en) * 1995-05-19 1998-04-07 Davis; Roger J. Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
WO1997002347A1 (en) * 1995-06-30 1997-01-23 Incyte Pharmaceuticals, Inc. A human map kinase homolog

Also Published As

Publication number Publication date
WO1998015618A1 (en) 1998-04-16
US6617117B1 (en) 2003-09-09
EP0932666A1 (de) 1999-08-04
CA2267656A1 (en) 1998-04-16
AU4630297A (en) 1998-05-05
ATE284955T1 (de) 2005-01-15
DE69731964T2 (de) 2005-12-08
JP2001501481A (ja) 2001-02-06
EP0932666B1 (de) 2004-12-15
AU727733B2 (en) 2000-12-21

Similar Documents

Publication Publication Date Title
ATE315654T1 (de) Diagnose und behandlung von mit aur-1 und/oder aur-2 assoziierten erkrankungen
WO1999024463A3 (en) Signal peptide-containing proteins
ATE269974T1 (de) Identifizierung und charakterisierung von interagierenden molekülen mittels automatisierter interagierender paarung
DE69739105D1 (de) Survivin, ein protein das zelluläre apoptosis hemmt, und dessen modulation
DK0593618T3 (da) Screeningsassay til påvisning af DNA-bindende molekyler
DK0529065T3 (da) Receptorbaserede fremgangsmåder til screening for amylinagonister og -antagonister
NO962991D0 (no) Zink-finger-proteinderivater og fremgangsmåter
ES2129622T3 (es) Receptores para interleuquina-10 de mamifero.
DE69433301D1 (de) Methoden zur erhöhung der biologischen aktivität von chemokinen
DE59814441D1 (de) Verwendung von kontrollflächen zur detektion von störproben in einem nachweisverfahren
IL139163A0 (en) A method of predicting the ability of compounds to modulate the biological activity of receptors
ATE284955T1 (de) Map-kinase: polypeptide, polynukleotide und ihre verwendung
DK1141237T3 (da) PTH-receptor og screeningsassay der anvender denne
ATE311443T1 (de) Methoden zur durchforstung (screenen) von proteinen
WO1997012039A3 (en) Sh2-containing inositol-phosphatase
WO1999030165A3 (en) Processes for identifying a solvent condition suitable for determining a biophysical property of a protein
ZA912303B (en) Protein partner screening assays and uses thereof
DE69831141D1 (de) Z2-19a, ein menschliches homolog von dem protein 2-19
WO2004078783A3 (en) Enzymes involved in apoptosis
WO2004015082A3 (en) Oncokinase fusion polypeptides associated with hyperproliferative and related disorders, nucleic acids encoding the same and methods for detecting and identifying the same
SE9701010D0 (sv) Antibody
DE59604894D1 (de) Testsystem zur erfassung der aktivität von nk-zellen
DE58906749D1 (de) Verwendung von feststoffen als antiblockadditive für markierflüssigkeiten.
DE3852498D1 (de) Enzymtest für biologische substanzen.
ATE385573T1 (de) Verfahren zum identifizieren von liganden der rna-polymerase sigma 70 untereinheit

Legal Events

Date Code Title Description
8364 No opposition during term of opposition